이뮤노프리사이즈 앤티바디즈(HYFT)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.41 (+1.44%), 시가총액 $0.06B, 52주 범위 $0.49 ~ $3.20.
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
이뮤노프리사이즈 앤티바디즈의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
이뮤노프리사이즈 앤티바디즈의 현재 주가는 $1.41 (+1.44%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
이뮤노프리사이즈 앤티바디즈의 시가총액은 약 $0.06B입니다.
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery an